Keywords: COPD; Elderly; Indacaterol;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: QMF149; Indacaterol; Mometasone furoate; Pharmacokinetics; Biopharmaceutical interaction
Keywords: Enfermedad pulmonar obstructiva crónica; Roflumilast; Indacaterol; Bromuro de aclidinio; Bromuro de glicopirronio;
A validated capillary electrophoretic method for the determination of indacaterol and its application to a pharmaceutical preparation
Keywords: Capillary electrophoresis; Determination; Indacaterol; Pharmaceutical;
Tai Chi and Pulmonary Rehabilitation Compared for Treatment-Naive Patients With COPD
Keywords: COPD; indacaterol; pulmonary rehabilitation; Tai Chi; 6MWD; 6-min walk distance; MCID; minimal clinically important difference; mMRC; modified Medical Research Council dyspnea score; PR; pulmonary rehabilitation; SGRQ; St. George's Respiratory Questionn
Synthesis and biological evaluation of β2-adrenoceptor agonists bearing the 2-amino-2-phenylethanol scaffold
Keywords: β2-Adrenoceptor agonists; Bronchodilators; Trantinterol; Indacaterol;
Role of dual bronchodilators in COPD: A review of the current evidence for indacaterol/glycopyrronium
Keywords: COPD; Dual bronchodilation; Glycopyrronium; Human; Indacaterol; QVA149;
Simultaneous spectrophotometric determination of indacaterol and glycopyrronium in a newly approved pharmaceutical formulation using different signal processing techniques of ratio spectra
Keywords: Indacaterol; Glycopyrronium; Numerical Differentiation; Savitsky–Golay; Fourier Transform
Evaluation of the anti-inflammatory effects of β-adrenoceptor agonists on human lung macrophages
Keywords: Alveolar macrophages; β-agonists; TNFα; Indacaterol; Salmeterol;
Long-term safety of glycopyrrolate: A randomized study in patients with moderate-to-severe COPD (GEM3)
Keywords: Bronchodilator; Chronic obstructive pulmonary disease; Safety; Glycopyrrolate; Long-acting muscarinic antagonist; Indacaterol;
Indacaterol and tiotropium combination therapy in patients with chronic obstructive pulmonary disease
Keywords: Chronic obstructive pulmonary disease; Combination therapy; Forced oscillation technique; Indacaterol; Tiotropium;
The impact of treatment with indacaterol in patients with COPD: A post-hoc analysis according to GOLD 2011 categories A to D
Keywords: Chronic obstructive pulmonary disease; GOLD categories; Indacaterol; Lung function; Symptoms;
Indacaterol vs tiotropium in COPD patients classified as GOLD A and B
Keywords: Indacaterol; Tiotropium; COPD; GOLD; Efficacy;
Effect of indacaterol on arterial blood gases in patients suffering from acute exacerbation of COPD
Keywords: Indacaterol; Arterial blood gases; COPD; Acute exacerbation;
Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in COPD patients
Keywords: Glycopyrronium; Indacaterol; Pooled analysis; QVA149; Safety; Tiotropium;
The effect of indacaterol during an acute exacerbation of COPD
Keywords: COPD; Exacerbation; Indacaterol; Salbutamol;
Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterol
Keywords: COPD; Indacaterol; Dose escalation; Lung function; Side effects;
Keywords: Colombia; COPD; cost-effectiveness; indacaterol
Chronic treatment with indacaterol and airway response to salbutamol in stable COPD
Keywords: COPD; Indacaterol; Formoterol; Salbutamol; Tolerance
Efficacy and safety of indacaterol and tiotropium in COPD patients according to dyspnoea severity
Keywords: Efficacy; Safety; Indacaterol; Tiotropium; Chronic obstructive pulmonary disease; Dyspnoea
Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use
Keywords: COPD; Formoterol; Indacaterol; Salmeterol; Tiotropium
A Year in Review: New Drugs for Older Adults in 2011
Keywords: fidaxomicin; indacaterol; rivaroxaban; roflumilast;
An investigation into the structure-activity relationships associated with the systematic modification of the β2-adrenoceptor agonist indacaterol
Keywords: β2-Adrenoceptor agonists; COPD; Indacaterol; Binding kinetics; Bronchodilator;
Assessing efficacy of indacaterol in moderate and severe COPD patients: A 12-week study in an Asian population
Keywords: Bronchodilator; COPD; Indacaterol; Asian population; Efficacy; Safety
Validation of an on-line solid-phase extraction method coupled to liquid chromatography–tandem mass spectrometry detection for the determination of Indacaterol in human serum
Keywords: Indacaterol; On-line SPE; LC–MS/MS; Validation; Human serum
Indacaterol therapy in patients with COPD not receiving other maintenance treatment
Keywords: Indacaterol; Tiotropium; COPD
Efficacy of Once-Daily Indacaterol Relative to Alternative Bronchodilators in COPD: A Patient-Level Mixed Treatment Comparison
Keywords: chronic obstructive pulmonary disease; indacaterol; individual patient data; mixed treatment comparison;
Effect of indacaterol on exercise endurance and lung hyperinflation in COPD
Keywords: Indacaterol; Exercise capacity; Inspiratory capacity; Bronchodilator agents
Sustained 24-hour efficacy of once daily indacaterol (300 μg) in patients with chronic obstructive pulmonary disease: A randomized, crossover study
Keywords: Indacaterol; Salmeterol; COPD; Bronchodilation; FEV1; Inspiratory capacity
Application of the classical Einthoven model of bronchoconstriction to the study of inhaled bronchodilators in rodents
Keywords: Bronchoconstriction; Einthoven model; Guinea pig; Rat; Ipratropium; Tiotropium; Albuterol; Salmeterol; Indacaterol; Methods;
Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: A 12-week study
Keywords: beta2-agonist; Bronchodilator; COPD; Indacaterol; Salmeterol
Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD
Keywords: Indacaterol; Formoterol; Salmeterol; Tiotropium; Dyspnoea; Health status
Nouveauté dans la prise en charge thérapeutique de la BPCO
Keywords: BPCO; Indacatérol; Distension; Exercice; Structure de l'indacatérol;
Indacaterol once-daily is equally effective dosed in the evening or morning in COPD
Keywords: Chronic obstructive pulmonary disease; Evening dose; Indacaterol; Morning dose; Salmeterol
24-h bronchodilator efficacy of single doses of indacaterol in Japanese patients with asthma: A comparison with placebo and salmeterol
Keywords: Asthma; Bronchodilator; Corticosteroids; Indacaterol; Salmeterol
Bronchodilator effects of indacaterol and formoterol in patients with COPD
Keywords: Bronchodilation; Chronic obstructive pulmonary disease; Forced expiratory volume in 1 s; Formoterol; Indacaterol; Inspiratory capacity
Lipid membrane interactions of indacaterol and salmeterol: Do they influence their pharmacological properties?
Keywords: Indacaterol; Salmeterol; Partitioning; Liposomes; Surface Plasmon Resonance (SPR); Kinetics; Membrane fluidity; Beta-2-adrenoceptor agonist; Rafts
A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison
Keywords: Indacaterol; COPD; Tiotropium; Efficacy; Safety; Dose
Safety, tolerability and efficacy of indacaterol, a novel once-daily β2-agonist, in patients with COPD: A 28-day randomised, placebo controlled clinical trial
Keywords: Indacaterol; β2-agonist; Bronchodilation; Safety; Tolerability